David C. Mulligan

7.8k total citations · 1 hit paper
164 papers, 4.8k citations indexed

About

David C. Mulligan is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, David C. Mulligan has authored 164 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Surgery, 59 papers in Hepatology and 44 papers in Epidemiology. Recurrent topics in David C. Mulligan's work include Organ Transplantation Techniques and Outcomes (66 papers), Liver Disease and Transplantation (51 papers) and Renal Transplantation Outcomes and Treatments (39 papers). David C. Mulligan is often cited by papers focused on Organ Transplantation Techniques and Outcomes (66 papers), Liver Disease and Transplantation (51 papers) and Renal Transplantation Outcomes and Treatments (39 papers). David C. Mulligan collaborates with scholars based in United States, China and United Kingdom. David C. Mulligan's co-authors include Adyr A. Moss, David D. Douglas, Russell H. Wiesner, Hugo E. Vargas, Richard B. Freeman, Kunam S. Reddy, Jorge Rakela, Thomas Byrne, Kristin L. Mekeel and Raymond L. Heilman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

David C. Mulligan

159 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement

2020 338 citations David C. Mulligan et al. profile →

Peers

David C. Mulligan

SURGE

HEPAT

EPIDE

TRANS

PRM

Ryutaro Hirose United States

Sander Florman United States

David Roth United States

Patricia A. Sheiner United States

Luiz Augusto Carneiro D’Albuquerque Brazil

Roy D. Bloom United States

David H. Van Thiel United States

Josh Levitsky United States

Ignazio R. Marino United States

Massimo Rossi Italy

Ryutaro Hirose United States

David C. Mulligan

2.4k ×1.0

SURGE

2.2k ×1.0

HEPAT

1.4k ×1.0

EPIDE

1.2k ×1.3

TRANS

427 ×0.7

PRM

Citations per year, relative to David C. Mulligan David C. Mulligan (= 1×) peers Ryutaro Hirose

Countries citing papers authored by David C. Mulligan

Since Specialization

Citations

This map shows the geographic impact of David C. Mulligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Mulligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Mulligan more than expected).

Fields of papers citing papers by David C. Mulligan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Mulligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Mulligan. The network helps show where David C. Mulligan may publish in the future.

Co-authorship network of co-authors of David C. Mulligan

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Mulligan. A scholar is included among the top collaborators of David C. Mulligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Mulligan. David C. Mulligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feizi, Alborz, John C. Stendahl, Matthew Harris, et al.. (2024). Contrast‐enhanced computed tomography for ex vivo assessment of human kidneys: A proof‐of‐concept study. Artificial Organs. 48(12). 1536–1548. 1 indexed citations

Albert, Claire, Matthew Harris, Sanjay Kulkarni, et al.. (2023). Honoring the gift: The transformative potential of transplant-declined human organs. American Journal of Transplantation. 23(2). 165–170.

Chouairi, Fouad, Clancy W. Mullan, Sounok Sen, et al.. (2021). Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies. PLoS ONE. 16(3). e0247789–e0247789. 15 indexed citations

Cohen, Elizabeth, et al.. (2021). Transversus Abdominis Plane Block with Liposomal Bupivacaine Reduces Post-Operative Opioid Requirements in Living Liver Donors. Anesthesiology and Pain Medicine. 7(4). 1 indexed citations

Hosgood, Sarah A., Melanie Reschke, Claire Albert, et al.. (2020). Lysis of cold-storage-induced microvascular obstructions for ex vivo revitalization of marginal human kidneys. American Journal of Transplantation. 21(1). 161–173. 45 indexed citations

McCarthy, Noel, et al.. (2020). An approach to teaching psychiatry to medical students in the time of Covid-19. Irish Journal of Psychological Medicine. 38(4). 293–299. 13 indexed citations

Hart, Allyson, David P. Schladt, Joshua Pyke, et al.. (2016). Predicting Outcomes on the Liver Transplant Waiting List in the United States. Transplantation. 100(10). 2153–2159. 28 indexed citations

Thiessen, Carrie, et al.. (2014). Written informed consent for living liver donor evaluation: Compliance with centers for medicare and medicaid services and organ procurement and transplantation network guidelines and alibi offers. Liver Transplantation. 20(4). 416–424. 2 indexed citations

Pruett, Timothy L., Emily A. Blumberg, David J. Cohen, et al.. (2012). A Consolidated Biovigilance System for Blood, Tissue and Organs: One Size Does Not Fit All. American Journal of Transplantation. 12(5). 1099–1101. 5 indexed citations

10.

Reddy, Kunam S., Marta Mazur, Harini A. Chakkera, et al.. (2010). Alemtuzumab with Rapid Steroid Taper in Simultaneous Kidney and Pancreas Transplantation: Comparison to Induction with Antithymocyte Globulin. Transplantation Proceedings. 42(6). 2006–2008. 18 indexed citations

11.

Gallegos‐Orozco, Juan F., Brie N. Noble, Bashar Aqel, et al.. (2009). Natural History of Post-Liver Transplantation Hepatitis C. Liver Transplantation. 15(12). 1872–1881. 70 indexed citations

12.

Reich, David J., David C. Mulligan, Peter L. Abt, et al.. (2009). ASTS Recommended Practice Guidelines for Controlled Donation after Cardiac Death Organ Procurement and Transplantation. American Journal of Transplantation. 9(9). 2004–2011. 249 indexed citations

13.

Mekeel, Kristin L., Adyr A. Moss, David C. Mulligan, et al.. (2009). Deceased Donor Kidney Transplantation from Donors with Acute Renal Failure due to Rhabdomyolysis. American Journal of Transplantation. 9(7). 1666–1670. 12 indexed citations

14.

Patel, B. M., Farouk Mookadam, Adyr A. Moss, et al.. (2009). Plasmapheresis therapy for rare but potentially fatal reaction to rituximab. Journal of Clinical Apheresis. 24(1). 28–31. 9 indexed citations

15.

Ko, Edmund, Erik P. Castle, Premal J. Desai, et al.. (2008). Utility of the Endovascular Stapler for Right-Sided Laparoscopic Donor Nephrectomy: A 7-Year Experience at Mayo Clinic. Journal of the American College of Surgeons. 207(6). 896–903. 29 indexed citations

16.

Blair, Janis E., et al.. (2007). Coccidioidomycosis masked by symptoms of end‐stage liver disease in transplant candidates. Transplant Infectious Disease. 9(2). 153–155. 6 indexed citations

17.

Post, D., David D. Douglas, & David C. Mulligan. (2005). Immunosuppression in liver transplantation. Liver Transplantation. 11(11). 1307–1314. 44 indexed citations

18.

Peter, Shawn St., et al.. (2004). Significance of Proximal Biliary Dilatation in Patients with Anastomotic Strictures After Liver Transplantation. Digestive Diseases and Sciences. 49(7-8). 1207–1211. 28 indexed citations

19.

Blair, Janis E., David D. Douglas, & David C. Mulligan. (2003). Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transplant Infectious Disease. 5(1). 3–8. 52 indexed citations

20.

Knauss, Thomas C., et al.. (1997). Influence of steroid withdrawal on proteinuria in renal allograft recipients. Clinical Transplantation. 11(5pt1). 395–398. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact